Controlling gene activation by enhancers through a drug-inducible topological insulator.
Taro TsujimuraOsamu TakaseMasahiro YoshikawaEtsuko SanoMatsuhiko HayashiKazuto HoshiTsuyoshi TakatoAtsushi ToyodaHideyuki OkanoKeiichi HishikawaPublished in: eLife (2020)
While regulation of gene-enhancer interaction is intensively studied, its application remains limited. Here, we reconstituted arrays of CTCF-binding sites and devised a synthetic topological insulator with tetO for chromatin-engineering (STITCH). By coupling STITCH with tetR linked to the KRAB domain to induce heterochromatin and disable the insulation, we developed a drug-inducible system to control gene activation by enhancers. In human induced pluripotent stem cells, STITCH inserted between MYC and the enhancer down-regulated MYC. Progressive mutagenesis of STITCH led to a preferential escalation of the gene-enhancer interaction, corroborating the strong insulation ability of STITCH. STITCH also altered epigenetic states around MYC. Time-course analysis by drug induction uncovered deposition and removal of H3K27me3 repressive marks follows and reflects, but does not precede and determine, the expression change. Finally, STITCH inserted near NEUROG2 impaired the gene activation in differentiating neural progenitor cells. Thus, STITCH should be broadly useful for functional genetic studies.
Keyphrases
- transcription factor
- genome wide
- copy number
- genome wide identification
- induced pluripotent stem cells
- dna methylation
- gene expression
- binding protein
- poor prognosis
- endothelial cells
- magnetic resonance imaging
- multiple sclerosis
- computed tomography
- clinical trial
- emergency department
- crispr cas
- long non coding rna
- magnetic resonance
- oxidative stress
- genome wide analysis
- pluripotent stem cells
- high density
- case control